Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Haferkamp

Showing results (121-130 of 298) with videos related to

Pageof 30
Sort By:
Life Sciences|February 2, 2016
Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitroJasmina Makarević, Igor Tsaur, Eva Juengel, et al.
Plos One|October 22, 2014
Amygdalin influences bladder cancer cell adhesion and invasion in vitroJasmina Makarević, Jochen Rutz, Eva Juengel, et al.
International Journal of Molecular Medicine|January 20, 2016
Amygdalin blocks the in vitro adhesion and invasion of renal cell carcinoma cells by an integrin-dependent mechanismEva Juengel, Masud Afschar, Jasmina Makarević, et al.
Plos One|August 20, 2014
Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2Jasmina Makarević, Jochen Rutz, Eva Juengel, et al.
Journal of Cellular and Molecular Medicine|May 1, 2014
Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cellsJasmina Makarević, Nassim Tawanaie, Eva Juengel, et al.
International Journal of Dermatology|March 22, 2017
Hidradenitis suppurativa gains increasing interest on World Wide Web: a source for patient information?Schapoor Hessam, Johannes Salem, Falk G Bechara, et al.
Scandinavian Journal of Urology|November 13, 2012
Prognostic value of melanoma-associated antigen A9 in renal cell carcinomaGencay Hatiboglu, Maria Pritsch, Stephan Macher-Goeppinger, et al.
Investigational New Drugs|July 18, 2012
The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258Stefan Vallo, Jens Mani, Matthias Stastny, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 10, 2024
Transglutaminase 2 promotes epithelial-to-mesenchymal transition by regulating the expression of matrix metalloproteinase 7 in colorectal cancer cells via the MEK/ERK signaling pathwayRoman A Blaheta, Jiaoyan Han, Elsie Oppermann, et al.
Cancers|June 7, 2019
Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In VitroEva Juengel, Iyad Natsheh, Ramin Najafi, et al.
Pageof 30

Showing results (121-130 of 298) with videos related to

Sort By:
Pageof 30
Life Sciences|February 2, 2016
Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitroJasmina Makarević, Igor Tsaur, Eva Juengel, et al.
Plos One|October 22, 2014
Amygdalin influences bladder cancer cell adhesion and invasion in vitroJasmina Makarević, Jochen Rutz, Eva Juengel, et al.
International Journal of Molecular Medicine|January 20, 2016
Amygdalin blocks the in vitro adhesion and invasion of renal cell carcinoma cells by an integrin-dependent mechanismEva Juengel, Masud Afschar, Jasmina Makarević, et al.
Plos One|August 20, 2014
Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2Jasmina Makarević, Jochen Rutz, Eva Juengel, et al.
Journal of Cellular and Molecular Medicine|May 1, 2014
Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cellsJasmina Makarević, Nassim Tawanaie, Eva Juengel, et al.
International Journal of Dermatology|March 22, 2017
Hidradenitis suppurativa gains increasing interest on World Wide Web: a source for patient information?Schapoor Hessam, Johannes Salem, Falk G Bechara, et al.
Scandinavian Journal of Urology|November 13, 2012
Prognostic value of melanoma-associated antigen A9 in renal cell carcinomaGencay Hatiboglu, Maria Pritsch, Stephan Macher-Goeppinger, et al.
Investigational New Drugs|July 18, 2012
The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258Stefan Vallo, Jens Mani, Matthias Stastny, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 10, 2024
Transglutaminase 2 promotes epithelial-to-mesenchymal transition by regulating the expression of matrix metalloproteinase 7 in colorectal cancer cells via the MEK/ERK signaling pathwayRoman A Blaheta, Jiaoyan Han, Elsie Oppermann, et al.
Cancers|June 7, 2019
Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In VitroEva Juengel, Iyad Natsheh, Ramin Najafi, et al.
Pageof 30